Indole-3-carbinol

Alternative Medicine Review

Volumn 10, Issue 4, 2005, Pages 337-342

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ESTROGEN RECEPTOR;

BREAST CANCER; COLON CANCER; DIET SUPPLEMENTATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HERPES SIMPLEX VIRUS; NONHUMAN; PROSTATE CANCER; REVIEW; TREATMENT INDICATION; WART VIRUS;

BREAST NEOPLASMS; FEMALE; HUMANS; INDOLES; MALE; PROSTATIC NEOPLASMS; SIMPLEXVIRUS; UTERINE CERVICAL NEOPLASMS;

EID: 29144442877     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Bradfield CA. Bjeldaaes LF. Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic mechanism. J Toxicol Environ Health 1987;21:311-323.
2. Arneson DW, Hurwitz A, McMahon LM, Robaugh D. Presence of 3.3'-diindolylmethane in human plasma after oral administration of indole-3-carbinol. Proc Annu Meet Am Assoc Cancer Res 1999;40:429.
3. De Kruif CA, Marsman JW, Venekamp JC, et al. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem Biol Interact 1991;80:303-315.
4. Stresser DM. Williams DE, Griffin DA, Bailey GS. Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats. Drug Metab Dispos 1995;23:965-975.
5. Yuan F, Chen DZ, Liu K, et al. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res 1999;19:1673-1680.
6. Liu H, Wormke M. Safe SH. Bjeldanes LF. Indole[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 1994;86:1758-1765.
7. Riby JE, Chang GH, Firestone GL, Bjeldanes LF. Ligand-independent activation ofestrogen receptor function by 3,3'-diindolylmethane in human breast cancer cells. Biochem Pharmacol 2000;60:167-177.
8. Shertzer HG, Senft AP. The micronutrient indole-3-carbinol: implications for disease and chemoprevention. Drug Metabol Drug Interact 2000;17:159-188.
9. Telang NT, Suto A, Wong GY, et al. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84:634-638.
10. Stoewsand GS, Anderson JL, Munson L. Protective effect of dietary Brussels sprouts against mammary carcinogenesis in Sprague-Dawley rats. Cancer Lett 1988:39:199-207.
11. Zeligs MA. Diet and estrogen status: the cruciferous connection. J Med Food 1998;1:67-81.
12. Auborn KJ, Woodworth C, DiPaolo JA, Bradlow HL. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. Int J Cancer 1991;49:867-869.
13. Chen I, McDougal A, Wang F, Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 1998;19:1631-1639.
14. Schneider J, Huh MM, Bradlow HL, Fishman J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 1984;259:4840-4845.
15. Suto A, Bradlow HL, Wong GY, et al. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 1993;27:193-202.
16. Hudson EA, Howells L, Ball HW, et al. Mechanisms of action of indole-3-carbinol as a chemopreventive agent. Biochem Soc Trans 1998;26:S370.
17. Cover CM, Hsieh SJ, Tran SH, et al. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 1998:273:3838-3847.
18. Manson MM, Hudson EA, Ball HW, et al. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver - predicting the outcome using early biomarkers. Carcinogenesis 1998;19:18291836.
19. Brew CT, Aronchik I, Hsu JC, et al. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Int J Cancer 2005;Sep 8:[Epub ahead of print].
20. Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 2005;106:641-649.
21. Rahman KW, Sarkar FH. Inhibition of nuclear translocation of nuclear factor-(kappa)B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 2005;65:364-371.
22. Rahman KM, Li Y, Sarkar FH. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 2004;48:84-94.
23. Schneider J, Kinne D, Fracchia A, et al. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 1982;79:3047-3051.
24. Muti P, Bradlow HL, Micheli A, et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 2000;11:635-640.
25. Zheng W, Dunning L, Jin F, Holtzman J. Correspondence re: G.C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomark. Prev., 6:505-509, 1997.
26. Cancer Epidemiol Biomark Prev 1998;7:85-86.
27. Kabat GC, Chang CJ, Sparano JA, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:505-509.
28. Ho GH, Luo XW, Ji CY, et al. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Med Singapore 1998;27:294-299.
29. Meilahn EN, De Stavola B, Alien DS, et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 1998;78:1250-1255.
30. Ursin G, London S, Stanczyk FZ, et al. Urinary 2-hydroxyestrone/16alpha- hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999;91:1067-1072.
31. Reed GA, Peterson KS, Smith HJ, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 2005;14:1953-1960.
32. Cover CM, Hsieh SJ, Cram EJ, et al. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells. Cancer Res 1999;59:1244-1251.
33. Meng Q, Goldberg ID, Rosen EM, Fan S. Inhibitory effects of indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat 2000;63:147-152.
34. Ge X, Yannai S, Rennert G, et al. 3,3'diindolylmethane induces apoptosis in human cancer cells. Biochem Biophys Res Commun 1996;228:153-158.
35. Hong C, Firestone GL, Bjeldanes LF. Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 2002;63:1085-1097.
36. Chang YC, Riby J, Chang GH, et al. Cytostatic and antiestrogenic effects of 2-(indol-3ylmethyl)-3,3'-diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Biochem Pharmacol 1999;58:825-834.
37. Chinni SR, Li Y, Upadhyay S, et al. Indole-3carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001;20:2927-2936.
38. Zhang J, Hsu B A JC, Kinseth B A MA, et al. Indole-3-carbinol induces a Gl cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer 2003;98:2511-2520.
39. Frydoonfar HR, McGrath DR, Spigelman AD. The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line. ANZ J Surg 2003:73:154-156.
40. Le HT, Schaldach CM, Firestone GL, Bjeldanes LF. Plant-derived 3,3'-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 2003;278:21136-21145.
41. Frydoonfar HR, McGrath DR, Spigelman AD. Inhibition of proliferation of a colon cancer cell line by indole-3-carbinol. Colorectal Dis 2002;4:205-207.
42. Newfield L, Goldsmith A, Bradlow HL, Auborn K. Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemo-prophylaxis with indole-3-carbinol. Anticancer Res 1993;13:337-341.
43. Nivva T, Swaneck G, Bradlow HL. Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds. Steroids 1994;59:523-527.
44. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP. Indole-3-carbinol. A novel approach to breast cancer prevention. Ann N Y Acad Sci 1995;768:180-200.
45. Bell MC, Crowley-Nowick P, Bradlow HL, et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 2000;78:123-129.
46. Chen DZ, Qi M, Auborn KJ, Carter TH. Indole3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV 16-transgenic preneoplastic cervical epithelium. J Nutr 2001;131:3294-3302.
47. Yuan F, Chen DZ, Sepkovic DW, et al. Antiestrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res 1999;19:1673-1680.
48. Rosen CA. Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 2004;18:248-253.
49. [No authors listed] Broccoli compound inhibits HSV. AIDS Patient Care STDS. 2003;17:609.
50. Telang NT, Katdare M, Bradlow HL, et al. Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol. Proc Soc Exp Biol Med 1997;216:246-252.
51. Rosen CA, Woodson GE, Thompson JW, et al. Preliminary results of the use of indole-3 carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 1998;118:810-815.
52. Wong GY, Bradlow L, Sepkovic D, et al. Dose-ranging study of indole-3-carbinol for breast cancer prevention. J Cell Biochem Suppl 1997:28-29:111-116.